Lipella Pharmaceuticals Inc. (LIPO): Capital Expenditures
Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$14.4K
Year ended 2023-12-31
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | $14.4K | n/a | 2025-03-28, From 2023-01-01 |